#a 1334

Collection of a 1334 news, found 1 news.

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

Sanofi's Investigational Semuloparin in Cancer Patients Initiating Chemotherapy Shows a 64 % Risk Re

  • 6th June 2011

-        - Results of Phase III SAVE-ONCO Study Selected for "Best of ASCO 2011" ...